Blood Diseases - HLBS-PopOmics -

Specific PHGKB|HLBS|PHGKB

Blood Diseases

- HLBS-PopOmics -

What's New

Last Posted: Dec 13, 2018

---

• Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study.  
  Dunleavy Kieron et al. The Lancet. Haematology 2018 Dec 5(12) e609-e617
• Importance of health guidance for family members of children with sickle cell disease.  
  Figueiredo Sarah Vieira et al. Revista brasileira de enfermagem 71(6) 2974-2982
• The current state of sickle cell trait: implications for reproductive and genetic counseling.  
  Pecker Lydia H et al. Hematology. American Society of Hematology. Education Program 2018 Nov 2018(1) 474-481
• White Paper: Pathways to Progress in Newborn Screening for Sickle Cell Disease in Sub-Saharan Africa.  
  Hsu Lewis et al. Journal of tropical diseases & public health 2018 6(2) 260
• Capacity building and networking to make newborn screening for sickle cell disease a reality in Haiti.  
  Saint Fleur Rony et al. Blood advances 2018 Nov 2(Suppl 1) 54-55
• Efficacy of the National Thalassaemia and Sickle Cell Disease Prevention Programme in Northern Greece: 15-Year Experience, Practice and Policy Gaps for Natives and Migrants.  
  Theodoridou Stamatia et al. Hemoglobin 2018 Dec 1-6
• Inherited hemolytic anemia: a possessive beginner's guide.  
  Mohandas Narla et al. Hematology. American Society of Hematology. Education Program 2018 Nov 2018(1) 377-381
• Measuring success: utility of biomarkers in sickle cell disease clinical trials and care. 
  Kalpatthi Ram et al. Hematology. American Society of Hematology. Education Program 2018 Nov 2018(1) 482-492
• Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease.  
  Fajgenbaum David C et al. Hematology. American Society of Hematology. Education Program 2018 Nov 2018(1) 318-325
• Accelerating Cures in the Genomic Age: The Sickle Cell Example  
  F Collins, NIH director blog, December 11, 2018
• A Proposed Approach for Implementing Genomics-Based Screening Programs for Healthy Adults  
  M. Murray and the Genomics and Population Health Action Collaborative, National Academies of Medicine, December 3, 2018
• Gene therapy for sickle cell disease.  
  Olowoyeye Abiola et al. The Cochrane database of systematic reviews 2018 Nov 11CD007652
• Prevalence of nonfounder BRCA1/2 mutations in Ashkenazi Jewish patients presenting for genetic testing at a hereditary breast and ovarian cancer center.  
  Frey Melissa K et al. Cancer 2018 Nov
• The current state of sickle-cell trait: implications for reproductive and genetic counseling.  
  Pecker Lydia H et al. Blood 2018 Nov
• Genetic Modifiers of Fetal Haemoglobin in Sickle Cell Disease.  
  Menzel Stephan et al. Molecular diagnosis & therapy 2018 Nov